Actavis announced it has received approval from the FDA for Telmisartan Immediate-Release Tablets, the generic version of Boehringer Ingelheim's Micardis.

Mylan announced it has received final approval from the FDA for its Abbreviated New Drug Application (ANDA) for Telmisartan Tablets, the generic version of Boehringer Ingelheim’s Micardis ...

Morningstar brands and products Company Portfolio ...

In addition to analyzing the ONTARGET study, the sponsor, FDA, and panel members spent the day examining data from TRANSCEND and PROFESS, two other telmisartan trials. In the end, panel members ...

Telmisartan, explained Bakris, is the longest-acting ARB, and there are clear differences in binding to the AT 1 receptor, with approximately 25% greater binding of telmisartan compared with losartan.

In a multicenter trial involving 20,332 patients who recently had an ischemic stroke, we randomly assigned 10,146 to receive telmisartan (80 mg daily) and 10,186 to receive placebo.

The TRANSCEND (Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease) study enrolled nearly 6,000 people worldwide who are intolerant to ACE inhibitors ...